Difference between revisions of "Phosphatases and Diseases"
From PhosphataseWiki
(→Cancer) |
|||
| Line 16: | Line 16: | ||
==== [[Phosphatase_Family_PPM#PPM1D|PPM1D]] (WIP1) ==== | ==== [[Phosphatase_Family_PPM#PPM1D|PPM1D]] (WIP1) ==== | ||
PPM1D as a frequent target of somatic mutation and as a potential therapeutic target in brainstem gliomas <cite>yan14</cite>. | PPM1D as a frequent target of somatic mutation and as a potential therapeutic target in brainstem gliomas <cite>yan14</cite>. | ||
| + | |||
| + | == Other diseases == | ||
| + | |||
| + | ==== [[Phosphatase_Gene_PTPRQ|PTPRQ]] and deafness ==== | ||
| + | See [http://omim.org/entry/603317 OMIM]. | ||
== References == | == References == | ||
Revision as of 04:04, 6 June 2014
Contents
Cancer
PTEN
PTPN11 (SHP2)
PTPRC (CD45)
DUSP3 (VHR)
DUSP3 is a negative regulator of ERK and JNK pathways in in vitro studies in several cell lines. Though its role is involved in human cancer, its has contradictory roles since it has been alternatively described as having tumor suppressive and oncogenic properties [1].
DUSP26 (MKP8)
DUSP26 (aka MKP8) is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma [2].
PPM1D (WIP1)
PPM1D as a frequent target of somatic mutation and as a potential therapeutic target in brainstem gliomas [3].
Other diseases
PTPRQ and deafness
See OMIM.
References
- Amand M, Erpicum C, Bajou K, Cerignoli F, Blacher S, Martin M, Dequiedt F, Drion P, Singh P, Zurashvili T, Vandereyken M, Musumeci L, Mustelin T, Moutschen M, Gilles C, Noel A, and Rahmouni S. DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Mol Cancer. 2014 May 15;13:108. DOI:10.1186/1476-4598-13-108 |
- Shang X, Vasudevan SA, Yu Y, Ge N, Ludwig AD, Wesson CL, Wang K, Burlingame SM, Zhao YJ, Rao PH, Lu X, Russell HV, Okcu MF, Hicks MJ, Shohet JM, Donehower LA, Nuchtern JG, and Yang J. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 2010 Sep 2;29(35):4938-46. DOI:10.1038/onc.2010.244 |
- Zhang L, Chen LH, Wan H, Yang R, Wang Z, Feng J, Yang S, Jones S, Wang S, Zhou W, Zhu H, Killela PJ, Zhang J, Wu Z, Li G, Hao S, Wang Y, Webb JB, Friedman HS, Friedman AH, McLendon RE, He Y, Reitman ZJ, Bigner DD, and Yan H. Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nat Genet. 2014 Jul;46(7):726-30. DOI:10.1038/ng.2995 |
